ABSTRACT Background: Nutrition plays a fundamental role in fetal growth and birth outcomes. Objective: We synthesized effects of dietary interventions before or during pregnancy on neonatal and infant outcomes. Design: Randomized controlled trials that assessed the whole diet or dietary components and neonatal or infant outcomes were included. Two authors independently identified articles to be included and assessed the methodologic quality. A meta-analysis was conducted separately for each outcome by using a random-effects model. Results were reported by dietary intervention as follows: 1) counseling, 2) food and fortified food products, or 3) a combination (counseling plus food) intervention, and 4) collectively for all dietary interventions. Results were subanalyzed by the nutrient of interest, country income, and BMI. Results: Of 2326 abstracts screened, a total of 29 randomized controlled trials (31 publications) were included in this review. Food and fortified food products were effective in increasing birth weight [standardized mean difference (SMD): 0.27; 95% CI: 0.14, 0.40; P , 0.01] and reducing the incidence of low birth weight (SMD: 20.22; 95% CI: 20.37, 20.06; P , 0.01). All dietary interventions and those focused on macronutrient intake also increased birth weight (P , 0.01) and length (P , 0.05) and reduced the incidence of low birth weight (P , 0.01). Dietary interventions in low-income countries and underweight or nutritionally at-risk populations increased birth weight (P , 0.05) and reduced the incidence of low birth weight (P = 0.01). No effects were seen for the following other outcomes: placental weight, head circumference, macrosomia, Apgar score, small for gestational age, large for gestational age, and perinatal mortality. Conclusion: Additional high-quality randomized controlled trials that test different dietary interventions are required to identify maternal diet intakes that optimize neonatal and infant outcomes.
INTRODUCTION
Nutrition before conception and during pregnancy is important to ensure a healthy pregnancy outcome (1) . Poor maternal nutrition during pregnancy has been shown to lead to adverse birth outcomes (2) (3) (4) (5) and long-term negative consequences for the developing fetus (5) (6) (7) (8) . A review by Abu-Saad and Fraser (2) summarized the observational evidence for maternal dietary intake and birth outcomes. The review concluded that maternal nutrition plays a crucial role in influencing fetal growth and birth outcomes, particularly low birth weight, preterm birth, and intrauterine growth restriction (2) . The challenge is to identify whether dietary intake during pregnancy plays a causal role in the incidence of adverse birth and infant outcomes with consideration given to the mechanisms at play. Research has shown the importance of diet as a prevention strategy for some adverse neonatal outcomes, particularly the role of folic acid for the prevention of neural tube defects (9) . The establishment of healthy eating behaviors in women, including adequately feeding women before and during pregnancy, is a priority for maternal health and birth outcomes (10) . "The first 1000 d" is a current global movement and international public health priority aimed at improving nutrition for the mother and child between a woman's pregnancy and her child's second birthday (11, 12) . The provision of the right nutrition during this 1000-d window can help ensure the child lives a healthy life (11, 12) and reduces the financial and social costs of poor health over the life course. There is a clear need to identify the best dietary interventions for pregnant women aimed at preventing adverse neonatal and infant outcomes. Even with small effect sizes, a simple dietary change as a public health nutrition strategy has the potential to affect a large number of women. Therefore, the objective of this study was to synthesize the best of the available evidence by conducting a systematic review and metaanalysis to determine whether dietary interventions before or during pregnancy have any effect on neonatal or infant outcomes. Dietary interventions could consist of dietary counseling, food and fortified food products, or a combination of both.
METHODS
The review protocol was developed by using the Cochrane Handbook for Systematic Reviews of Interventions (13) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses for reporting methods and outcomes (14, 15) . Details of the review protocol, including eligibility criteria, search strategy, selection process, and data extraction have been described previously (16) . Briefly, the inclusion and exclusion criteria for the selection of studies and flow diagram are presented in Table 1 (17) and Figure 1 , respectively.
The main measure of effect was the standardized mean difference (SMD) 4 . The SMD was used to express the size of the intervention effect in each publication relative to the variability observed within that study. The SMD is calculated by taking the difference in the mean outcome between the intervention and control groups in one publication divided by the pooled SD for the outcome across the whole trial. This method resulted in all measurements standardized to SD units. A secondary measure of effect, the raw mean difference (RMD), was used to present results in a scale that can be more easily interpreted (eg, grams for birth weight and centimeters for length). CIs have not been included for the RMD to emphasize the appropriateness of the SMD as the primary measure of effect. The single trial that contained more than one control group (18) had its effects averaged because there were no significant differences on neonatal outcomes (19) . Trials that contained more than one intervention group (20) (21) (22) (23) had their effects taken from the group and showed statistically significant results on neonatal (20) (21) (22) and infant outcomes (23) . Dichotomized outcomes had log odds and SEs approximated to the SMD (24, 25) , and means and variance were approximated for trials that reported medians (26) . Trials that reported outcomes with zero counts for both intervention and control groups were excluded from the analysis. For outcomes that reported zero counts for one intervention group only, ORs and 95% CIs were approximated (27, 28) . The I 2 statistic was used to describe heterogeneity, and a random-effects model was used for meta-analyses for each neonatal and infant outcome, with random weights applied for each study. Additional analyses were performed for each outcome by dietary intervention type, combined dietary interventions, and subgroup analyses performed for each outcome by the nutrient of interest, BMI, and country income.
Funnel plots were used to investigate the presence of a potential bias, and Egger's test was used to test for funnel plot asymmetry (29) . Statistical analyses were performed with the metan command in the statistical software package Intercooled Stata (version 12; StataCorp LP) (30) . P , 0.05 was considered statistically significant.
RESULTS

Description of studies
The trial-selection process is summarized in Figure 1 . Of 2326 articles that were screened, data were included from 29 randomized controlled trials (RCTs) (31 publications), which included 10,026 participants. The earliest published study was in 1978 (31) and the latest published study was in 2011 (32) (33) (34) (35) . Twenty-three publications were performed in high-income Organisation for Economic Co-operation and Development countries as follows: 10 publications in the United States, 4 publications in the Netherlands, 3 publications in Denmark, 2 publications in Finland, and one publication each in Australia, Greece, Italy, and Norway ( Table 2) .
The methodologic quality and characteristics of included studies are shown in Table 2 . Sixteen publications compared dietary counseling with standard antenatal care (no active intervention) (20, (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) , 2 publications of which came from a trial in the Netherlands that examined the effect of sodium restriction (45, 46) . Fourteen publications evaluated the effect of specific foods and fortified food products (18, 21-23, 31, 32, 48-55) , 2 publications of which came from the Columbian Longitudinal Study of Malnutrition and Intellectual Development (31, 54) . One publication from the Finnish Mother-Infant Nutrition and Probiotic Intervention assessed the effect of combined dietary counseling and food and fortified food products (56) .
All but one publication (52) studied the effect of dietary intervention during pregnancy on neonatal and infant outcomes. McDonald et al (52) included a prepregnancy (preconception) dietary intervention. Preconception was defined as #3 mo before pregnancy. Twenty-three (of 31) publications included 2 groups of dietary intake (intervention) compared with usual care or dietary intake (control). Dietary interventions ranged in duration from 10 wk (23) to .40 wk (prepregnancy intervention) (52) . Dietitians or nutritionists were the most frequent dietary intervention providers (11 publications) , and macronutrients (25 publications) were more commonly targeted in the intervention than were micronutrients (6 publications). Fifteen publications did not report dietary data (18, 22, 32, 34-37, 42-45, 48, 49, 53, 55) , and 13 of these publications did not conduct nutritional assessments during the intervention period (18, 22, 35-37, 42-45, 48, 49, 53, 55) . Eight trials (9 publications) recruited women who were underweight or nutritionally at risk (21, 22, 31, 40, 49, (51) (52) (53) (54) , whereas 5 trials recruited overweight or obese women as their target population (32, 34, 35, 44, 47) . Neonatal outcomes included placental weight, birth weight, length, head circumference, low birth weight, macrosomia, Apgar score (at 5 min of age), Apgar score (,7 at 5 min of age), large for gestational age, small for gestational age, and perinatal mortality (including stillbirth and early fetal, fetal, neonatal, and perinatal mortality). Infant outcomes included body-size measures (including weight and height).
Effects of dietary intervention
Effects of dietary intervention components and all dietary intervention trials on meta-analyzed neonatal and infant outcomes are shown in Table 3 . There was one trial in our review on a combination (counseling plus food) dietary intervention (56). Aaltonen et al (56) analyzed the effect of an intervention on the neonatal outcomes birth weight, length, head circumference, and Apgar score (at 5 min of age) and was meta-analyzed with all dietary intervention trials only.
Neonatal outcomes
Twenty-nine RCTs (31 publications) (n = 10,026 women) studied the effect of dietary intervention on neonatal outcomes (18, (20) (21) (22) (23) . Fifteen RCTs studied the effect of dietary counseling on birth weight (n = 3287 women) (20, (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) 47) , and 12 RCTs studied the effect of food and fortified food products (n = 5547 women) (18, 21-23, 32, 48-52, 54, 55) . A meta-analysis showed a significant effect for an increase in birth weight (SMD: 0.27; 95% CI: 0.14, 0.40; P , 0.01, I 2 = 74%) ( Figure 2 ) for food and fortified food products. With the use of an RMD, this result translated to a mean increase of 125 g from a mean birth weight of 3169 g. A meta-analysis showed no effect of dietary counseling on birth weight. However, overall there was a significant increase in birth weight for all dietary intervention trials (28 trials) (SMD: 0.19; 95% CI: 0.06, 0.32; P , 0.01, I 2 = 87%), which was largely attributable to interventions that provided food and fortified food products (Figure 2 ). With the use of an RMD, this result translated to a mean increase of 62 g from a starting weight of 3277 g. Data showed a moderate heterogeneity for food and fortified food products and a high heterogeneity for dietary counseling and all dietary intervention trials. Pooled trials showed no evidence of bias.
Six RCTs studied the effect of dietary counseling on length (n = 1383 women) (37, 39, 40, 43, 46, 47) . Seven RCTs studied the effect of food and fortified food products on length (n = 3656 women) (18, 32, 48, 49, 51, 52, 55) . There were no effects for either type of dietary intervention on length. However, when pooled in a meta-analysis, all dietary intervention trials (14 trials) showed a significant increase in length (SMD: 0.08; 95% CI: 0.01, 0.15; P = 0.03, I 2 = 25%) ( Figure 3 ). This amount translated to a mean increase of 0.07 cm from a starting length of 50 cm. Data showed no evidence of heterogeneity or presence of bias.
Two RCTs studied the effect of dietary counseling on low birth weight (n = 908 women) (40, 42) . Eight trials studied the effect of food and fortified food products (n = 4530 women) on low birth weight (18, 21, 49, (52) (53) (54) (55) 57) , showing a significant reduction in the incidence (SMD: 20.22; 95% CI: 20.37, 20.06; P , 0.01, I 2 = 24%) ( Figure 4 ). With the use of an RMD, this result translated to an OR of 0.73 or a 27% reduction in odds of having a low-birth-weight infant. A meta-analysis of all dietary intervention trials (10 trials) also showed a significant reduction in the incidence of low birth weight (SMD: 20.19; 95% CI: 20.32, 20.05; P , 0.01, I 2 = 19%) with reduced odds of w24% (Figure 4 ). Data showed slight heterogeneity and no evidence of bias. 
DIETARY INTERVENTIONS DURING PREGNANCY
There was no effect of dietary intervention components or all dietary intervention trials on placental weight, head circumference, macrosomia, Apgar score (at 5 min of age and ,7 at 5 min of age), small for gestational age, and large for gestational age (Table 3) .
Perinatal mortality
Ten RCTs (n = 6125 women) studied the effect of dietary intervention on perinatal mortality (23, 31, 35, 40-43, 48-50 ). Five RCTs studied the effect of dietary counseling on perinatal mortality (n = 1778 women) (35, (40) (41) (42) (43) ; the other 5 trials provided food and fortified food products (n = 4347 women) (23, 31, (48) (49) (50) . A meta-analysis showed no effect of dietary intervention components or all dietary intervention trials on perinatal mortality with no evidence of heterogeneity or bias.
Infant body-size measures
Three RCTs (n = 1773) studied the effect of dietary intervention on infant body-size measures (23, 39, 51) . All trials examined the effect of dietary intervention on weight and height measures; however, a meta-analysis could not be performed because of the insufficient reporting of results.
Subanalysis by nutrient of interest, BMI, and country income
There were significant differences in effects of dietary interventions on birth weight, length, and low birth weight on the basis of the nutrient of interest, BMI, and country income ( Table 4) .
Trials that altered the macronutrient composition of dietary interventions showed increases in birth weight (P , 0.01) and length (P = 0.03) and a reduction in the incidence of low birth weight (P = 0.01). With the use of an RMD, these results translated to an increase of 72 g in birth weight (from a starting weight of 3240 g), 0.2 cm in length (from a starting length of 50 cm), and a 0.76 OR or 24% reduction in odds for low birth weight, respectively.
Dietary interventions conducted with underweight or nutritionally at-risk pregnant women, showed an increase in birth weight (P , 0.01) and a reduction in the incidence of low birth weight (P = 0.03). With the use of an RMD, these results translated to an increase of 101 g from a starting weight of 3112 g and a 0.76 OR or 24% reduction in odds for low birth weight. Trials that involved all weight categories showed a significant increase in length (P = 0.03) only, which corresponded to a 0.5-cm increase from a starting length of 51 cm.
Dietary interventions conducted in low-income countries showed an increase in birth weight (P = 0.04) and a reduction in the incidence of low birth weight (P , 0.01). With the use of an RMD, these results translated to an increase of 94 g (from a starting weight of 3086 g) and a reduction of 37% in odds (or a 0.63 OR), respectively. Trials in high-income countries showed increases in birth weight (P = 0.04) and lengths (P = 0.04) that corresponded to 49-g (from a starting weight of 3406 g) and 0.5-cm (from a starting length of 51 cm) increases, respectively.
The neonatal outcomes Apgar score (at 5 min of age and ,7 at 5 min of age) and large for gestational age were not sub-analyzed because they contained only 3 RCTs. There was no effect on any other neonatal outcome. 6th Edition (1979); Editorial, Antarctica.
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DISCUSSION
Summary of main findings
This review showed dietary intervention to be an effective strategy for increasing the size of the infant at birth. In particular, food or fortified food products increased birth weight (by w125 g) and reduced the incidence of low birth weight (by an w27% decrease in odds). After all dietary interventions were combined, both the increase in birth weight and reduction in low birth weight remained significant (62 g and 24% decreased odds, respectively), and length also increased (0.07 cm). From subgroup analyses, it appeared that the largest gains in birth size as a result of dietary intervention were made in underweight and nutritionally at-risk populations in both high-and low-income countries and dietary interventions that focused on macronutrients. To our knowledge, this is the largest systematic review of dietary interventions during pregnancy on neonatal and infant outcomes.
Interpretation
Macronutrient or balanced protein-energy food supplementation is considered one of the most promising dietary interventions in the prevention of adverse perinatal outcomes (58, 59) . Results from our previous work on the effect of dietary intervention on pregnancy outcomes (16) as well as our current review reinforce this view. These reviews showed that food or fortified food products and macronutrient dietary intervention trials increase the size of the infant at birth and reduce the incidence of preterm delivery, with no effect on macrosomia or a prolonged length of gestation.
There were 15 trials that reported on preterm delivery, and 28 trials that reported on birth weight. The combination of both preterm delivery and birth-weight outcomes were reported in 14 trials. Of these trials, 43% (n = 6) of them showed a reduction in preterm delivery and a corresponding increase in birth weight, which would be expected with an increase in the length of gestation. Despite decreased odds of a preterm delivery as a categorical variable, our pregnancy review also showed no increase in the length of gestation as a continuous variable (16) . There were 20 trials that reported on the length of gestation, but of these studies, only 10 trials reported both preterm delivery and length of gestation. There was relatively high heterogeneity in trials that reported on the length of gestation (I 2 = 61%) than all trials that included preterm delivery (I 2 = 15%) (16) . In this review, less than one-half of individual food or fortified food product trials (5 of 12) showed significant effects on birth weight. The combination of studies in our meta-analysis increased the statistical power and improved point estimates. All trials of food and fortified food products targeted macronutrients (primarily energy, protein, and fat) in their interventions with the exception of Bech et al (48) who evaluated the impact of reducing caffeine intake during pregnancy. Dietary interventions that were effective in increasing the size of the infant included a milk-based fortified product (21), high-energy and -protein supplement biscuits (49) , and a DHA cereal-based bar (32) . The provision of a food or fortified food product in addition to the usual diet during pregnancy can increase overall energy intake and subsequently increase the size of the infant at birth.
The effect of dietary counseling during pregnancy was not consistent across trials. There were no significant results of dietary counseling on birth weight because one-half of included trials (8 trials) showed an increase in birth weight with dietary counseling, and the other one-half of trials (7 trials) showed a decrease in birth weight. Dietary counseling interventions shown to significantly increase birth weight and showed the strongest effects in the meta-analysis included trying to increase dairy intake in adolescent pregnancies (20) , providing recommendations on nutritional needs during pregnancies of low-income women (38) , and dietary advice to achieve national recommendations (35) . In comparison, dietary counseling interventions shown to decrease birth weight included guidelines for specific energy requirements (36, 37, 44, 47) , recommendations to modify fat intake (33, 39) , and providing counseling to reduce sodium intake (45) . Of trials that provided counseling that focused on achieving national dietary recommendations (6 trials), one trial showed an increase in birth weight (35) . An increase in birth weight may be from a combination of a woman beginning her pregnancy obese and exceeding upper thresholds for gestational weight gain (60, 61) .
High birth weight (births .4000 g) has been associated with increased risk of obesity later in life (62); however, Risnes et al (63) have shown an overall reduction in adult mortality with a higher birth weight (6% reduction per kilogram increase in birth weight). Overall, the appropriateness of implementing dietary strategies to increase birth weight must be considered in the context of the target population. Furthermore, birth weight is only a surrogate marker for body composition, which has a much stronger biological basis for longer-term disease propensity. Specifically, increases in birth weight that increase visceral fat disproportionately to lean muscle mass are likely to be more harmful than protective (64) (65) (66) (67) . In an attempt to provide a more clinically relevant measure of the effect size for birth weight (because the SMD cannot be used to interpret absolute or relative differences in clinically meaningful outcomes) we have presented raw data for one trial. Smuts et al (55) showed an increase in birth weight of 103 g from an average birth weight of 3158 g. The SMD in this trial (SMD: 0.19; 95% CI: 0.06, 0.32) was similar to the SMD for the pooled effect for this outcome in this review. However the absolute effect may vary depending on the population's characteristics (eg, the average birth weight and SD for the population).
Implications for practice and research
Infant size at birth (small for gestational age, low birth weight, and intrauterine growth restriction) has been associated with increased risk and development of both short (perinatal mortality and morbidity) (68) and long-term (diabetes and cardiovascular disease) (32, 68) health problems compared with infants born appropriate for gestational age (2500-4000 g) (69) (70) (71) (72) . In our review, dietary interventions during pregnancy were associated with increased birth weight and length and a reduced incidence of low birth weight, with no strong evidence for any other neonatal or infant outcome.
This review advances our understanding of the role of nutrition for a healthy birth outcome. The provision of nutrition education as well as food or fortified food products to pregnant women, particularly those who are underweight, at nutritional risk, or come from a low-income country, is likely to increase the size of the infant at birth with important health and financial ramifications.
Limitations
Despite the broad scope of this review, very few dietary intervention trials contributed data to each neonatal and infant outcome with the exception of birth weight (n = 28). For this reason, some of the outcomes were not reported, and other outcomes were underpowered. There were very few trials on dietary interventions, particularly a combination (both counseling and food) intervention, and some neonatal and infant outcomes. Trials should measure and report on a range of neonatal and infant outcomes so that effects of diet on neonatal and infant outcomes can be determined even if only by a meta-analysis. The quality across included trials was mostly positive (61%; 39% neutral). However, many trials did not report on how effective their dietary interventions were on achieving a dietary change. There was a moderate to high heterogeneity for the neonatal outcomes placental weight, birth weight, head circumference, Apgar score (at 5 min of age), and large for gestational age with no evidence of bias for any outcome. Subgroup 1 The main measure of effect was the SMD. The SMD was determined by taking the difference in the mean of an outcome between the intervention and control groups in one publication and dividing it by the pooled SD for the outcome across the whole trial. The meta-analysis focused on outcomes with $3 trials that contributed data to pooled results. There were no studies for subgroup analyses for BMI (overweight and obese) on placental weight, macrosomia, and small for gestational age. There were no studies of low-income countries on low birth weight and small for gestational age. RMD, raw mean difference; SMD, standardized mean difference.
2 The trial by Metcoff et al (53) was not included in meta-analyzed outcomes of birth weight, length, and head circumference because the authors did not present results. 3 The secondary measure of effect was the RMD, which was the unadjusted mean difference in the outcome between intervention and control groups. RMDs are presented in common units for each outcome. Categorical outcomes are reported as ORs.
4 P values apply to SMDs only. 5 Included trials that did not restrict BMI within the target population. 6 Micronutrient of interest was sodium.
analyses were undertaken, which did not explain the heterogeneity, which may have been due to the duration and varying intensity of included trials. A small number of trials (n = 4) had their effects taken from the intervention group exhibiting significant results with the nonsignificant group removed from the meta-analysis. This method would have biased the results in favor of a greater effect size than if the nonsignificant intervention was included.
In conclusion, there is evidence that dietary intervention during pregnancy can increase the size of the infant at birth. Interventions that provide food and fortified food products or target pregnant women who are underweight, nutritionally at risk, or from a low-income country are the most-promising strategies to increase the size of the infant at birth. However, size is just a surrogate marker for other health and economic outcomes. In addition, large, high-quality RCTs that investigate combination (counseling plus food) dietary intervention and micronutrient provision from food are needed. Future trials spanning preconception, the duration of pregnancy, and even between pregnancies are needed to advance our understanding of optimal maternal nutrition for maternal-child health.
